#Pandemicrecovery

A major new report brings much-needed relief to the global cancer community, revealing that advanced cancer diagnoses in the United States—which spiked during the early days of the COVID-19 pandemic—have now returned to levels seen before the global crisis. Published Monday in the journal Cancer, the study offers a broad analysis of U.S. cancer statistics, addressing widespread fears that disruptions to screening during the pandemic would drive a lasting increase in late-stage cancer cases and, ultimately, higher death rates (AP News).

A major new analysis offers relief to the global cancer community: advanced cancer diagnoses in the United States have largely returned to pre-pandemic levels after a spike during the COVID-19 crisis. The study, published in Cancer, examined U.S. cancer statistics and found that disruptions to screening did not cause a lasting rise in late-stage cancers or cancer deaths. This insight provides guidance for policymakers and health planners in Thailand as the country redoubles its screening efforts.

A new study reported in The Lancet Infectious Diseases finds that people who have had COVID-19 face a higher risk of various infections for up to a year after the initial illness. The research suggests lasting changes in the immune system that can leave some individuals more susceptible to bacterial, fungal, and viral infections, including sepsis and respiratory illnesses. For Thai readers, the findings emphasize ongoing health considerations after even mild COVID-19 cases and the importance of continued health monitoring.